Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Virbac: Availability of the first half-yearly financial report as of June 30, 2017

Posted on: 11 Sep 17

Availability of the first half-yearly financial report as of June 30, 2017

Public release - September 11 th , 2017

Virbac announced today that the 2017 half-yearly financial report is now available and has been filed with the French financial markets authority (AMF - Autorités des marchés financiers ).

The half-yearly financial report is available:
·          on our website: under the section Investors - Financial reports - 2017,
·          or on request, under legal and regulatory conditions.

This document includes:

·          the 2017 half-yearly management report,
·          the condensed consolidated financial statements at June 30, 2017,
·          the statutory auditors' review report on the 2017 half-yearly financial information,
·          the statement of responsibility for the half-yearly financial report.

NYSE Euronext - Compartiment A - code ISIN: FR0000031577 / MNEMO: VIRP
Corporate Finance: tel. 33 4 92 08 71 32 - E-mail:

Virbac - Shaping the future of animal health

Virbac: Availability first half-yearly financial report June 30, 2017

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Virbac via GlobeNewswire

Last updated on: 12/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.